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Accepted 4 February 2016Immunoassays based on monoclonal antibodies (mAbs) are highly sensitive for the detection of polycyclic
aromatic hydrocarbons (PAHs) and can be employed to determine concentrations in near real-time. A sensitive
genericmAb against PAHs, named as 2G8,was developed by a three-step screening procedure. It exhibited nearly
uniformly high sensitivity against 3-ring to 5-ring unsubstituted PAHs and their common environmental meth-
ylated PAHs, with IC50 values between 1.68 and 31 μg/L (ppb). 2G8 has been successfully applied on the KinExA
Inline Biosensor system for quantifying 3–5 ring PAHs in aqueous environmental samples. PAHswere detected at
a concentration as low as 0.2 μg/L. Furthermore, the analyses only required 10 min for each sample. To evaluate
the accuracy of the 2G8-based biosensor, the total PAH concentrations in a series of environmental samples an-
alyzed by biosensor and GC–MS were compared. In most cases, the results yielded a good correlation between
methods. This indicates that generic antibody 2G8 based biosensor possesses signiﬁcant promise for a low
cost, rapid method for PAH determination in aqueous samples.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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Polycyclic aromatic hydrocarbons (PAHs), a group of organic
compounds composed of two ormore blended aromatic rings, are an im-
portant class of environmental pollutants [4,13]. PAHs are a concern
because several of its members have been known to cause cancer in
humans [9]. The U.S. Environmental Protection Agency (EPA) has
identiﬁed 16 PAHs as priority pollutants because of their suspected carci-
nogenicity andhigh toxicity [1]. Environmental PAHs are typically present
in complex mixtures and are mainly formed during the incomplete com-
bustion of organic matter [17]. Because PAHs are found naturally in the
environment but are also man-made, one can be exposed to PAHs in a
number of ways, including air, water and food [19]. Traditionally, PAHs
are analyzed by high performance liquid chromatography (HPLC) com-
bined with ultraviolet (UV) absorption or ﬂuorescence detection; or by
gas chromatography (GC) combined with mass spectrometry or ﬂame
ionization detection [17,21]. These methods are sensitive, but are depen-
dent on sophisticated equipment and often require complicated sample
preparation steps, which can increase the time and effort for analysis.
Antibody-based immunoassays are widely employed in environ-
mental PAH analysis because of their low cost, rapidity and sensitivity
[15,16,26]. Therefore, a number of monoclonal antibodies (mAbs). This is an open access article underagainst PAHs have been described in the recent past [14,23,24]. Although
those mAbs differ in terms of their sensitivity and selectivity, they gener-
ally target one or a few select PAHs, andmany have been developed to be
selective to benzo(a)pyrene (BaP). Environmental samples typically con-
tain complex mixtures of PAHs so there is a need for the rapid simulta-
neous determination of total PAHs in one analytical step for
environmental fate studies where mapping of PAH gradients is needed.
A near real-time assay for total PAH concentrations will allow the analyst
to evaluate spatial or temporal changes in total PAH concentrations not
economically feasible by traditional methods. To develop immunoassays
for the quantitative detection of total PAHs in environmental samples, it
is necessary to have antibodies with generic high afﬁnity against PAHs.
Our laboratory has employed a fast, highly sensitive, automated sys-
tem, KinExA Inline BioSensor [28], (Sapidyne Instruments) to serve as a
biosensor for PAH detection, which allows near real-time assessment of
PAHs in aquatic samples [25]. The technology is based on ﬂuid phase in-
teraction of the target with a selective antibody and detection of ﬂuores-
cence inhibition [5]. This method requires only 3 min for a quantitative
response and an additional 7 min for sensor regeneration. The next
phase of development was to seek new PAHmAbs with broad selectivity
that could be employed in the biosensor to assess PAH concentrations in a
wide range of environmental samples. Therefore, the focus of this project
was the development and evaluation of a generic anti-PAHmAbaswell as
evaluating it in our inline biosensor system for the accurate detection of
total PAH concentrations in environmental samples.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. ELISA inhibition curves for mAb 2G8 against different PAHs. (A) mAb 2G8 binding
against class unsubstituted PAHs, with IC50 values between 1.68 and 9.44 μg/L.(B) mAb
2G8 binding against class alkylated PAHs, with IC50 values between 1.92 and 31 μg/L.
Each data point is the average of 3 times duplicate samples. The coefﬁcients of variation
(n = 3) were between 0.5% and 7.9%.
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2.1. Chemicals and reagents
PAH standards (phenanthrene, anthracene, pyrene, chrysene,
benzo[a]pyrene) were obtained from Sigma Aldrich (St. Louis, MO,
USA). Keyhole limpet hemocyanin (KLH), bovine serum albumin (BSA)
and 1-pyrene butyric acid were purchased from Fisher Scientiﬁc (Pitts-
burgh, PA, USA). Anhydrous N,N-dimethylformamide (DMF) was from
Acros Organics (Morris Plains, NJ, USA). Bicinchoninic acid (BCA) protein
assay Kit, N-hydroxysuccinimide (NHS) and dicyclohexylcarbodiimide
(DCC) were obtained from Pierce (Rockford, IL, USA). HAT medium
supplement, Freund's complete adjuvant (FCA) and Freund's incomplete
adjuvant (FIA) were also purchased from Sigma-Aldrich (St. Louis, MO,
USA). RPMI-1640 medium with L-glutamine and fetal bovine serum
(FBS)were obtained fromHyclone (Logan,UT, USA). Goat anti-mouse im-
munoglobulin G secondary antibody conjugated with horseradish perox-
idase (GAM IgG-HRPO) was purchased from Jackson Immunoresearch
(West Grove, PA, USA). Tissue culture plates and microtiter plates were
supplied by Costar (Corning, NY, USA). The polymethylmethacrylate
beads were obtained from Sapidyne Instruments (Boise, ID, USA). The
ﬂuorescent dye AlexaFluor 647 came from Invitrogen (Carlsbad, CA,
USA). All other reagents were of analytical grade and purchased from
Fisher Scientiﬁc (Pittsburgh, PA, USA).
Balb/c mice were bred at our own facility from stock originally pur-
chased from the Jackson Laboratory (Bar Harbor, ME, USA). All animal
protocols were reviewed and approved by the Institutional Animal
Care and Use Committee of the College of William and Mary.
2.2. Preparation of PAH-protein conjugates
Since PAHs are low molecular weight and devoid of antigenicity,
they must be coupled to a protein carrier in order to elicit an immune
response. For this study a derivative of pyrene, 1-pyrene butyric acid
(PBA) was chosen as the hapten for immunization. The conjugations
of the immunogen 1-pyrene butyric acid-KLH (PBA-KLH) and the
screening antigen PBA-BSA were both carried out by the method de-
scribed in the Pierce N-hydroxysulfosuccinimide (S-NHS) and 1-Ethyl-
3-(3-dimethylaminopropyl)carbodiimide (EDC) protocol adapted
from Grabarek and Gergely [7] with some modiﬁcations. Brieﬂy, PBA
hapten was dissolved in MeOH at 1 mg/ml. S-NHS and EDC were
added to each of two aliquots of the hapten solution at a ﬁnal concentra-
tion of ~500 mM and ~200 mM respectively, and rotated for 15 min at
room temperature. To quench the EDC, 2-mercaptoethanol (20 mM)
was added to each aliquot and rotated for 10 min. Any precipitate was
removed by centrifugation at 12,000 rpm for 5 min at room tempera-
ture; the supernatant contained the activated hapten. A 1 mg/ml
solution of both BSA and KLH was made in 0.1 M sodium phosphate,
pH = 7.5. The PBA was then conjugated to the carrier by mixing 1 ml
of the activated hapten to either 10 ml of BSA or 20 ml of KLH to yield
a molar ratio of ~20:1 (PBA:BSA) and ~50:1 (PBA:KLH). The mixtures
were covered in foil and allowed to react for ~2–3 h on a rotator at
room temperature. To remove excess reactants, the two conjugates
were dialyzed separately in 1× PBS with a minimum of three 1 h 1 L
changes, including one overnight, at 4 °C. The conjugates were ﬁlter-
sterilized through 0.22 μm ﬁlters, and a ﬁnal protein concentration
was determined by bicinchoninic acid (BCA) protein assay (Pierce)
and read on a microtiter plate reader (MTX Lab Systems, Vienna, VA,
USA) using a 540 nm ﬁlter.
2.3. Immunization and generation of hybridoma cells
Five 10-week-old female Balb/cmicewere immunizedwith 100 μl of
a 1:1 FCA emulsion containing 50 μg of PBA-KLH by intraperitoneal
injection. Antisera were collected from the tail vein of each mouse at
3 weeks and 6 weeks post-immunization and assayed for antibodytiter determination by using an enzyme-linked immunosorbent assay
(ELISA) procedure [8]. The ELISA for titer was carried out as described
by Spier et al. [24]. The mouse whose antiserum exhibited the highest
titer was given an intravenous booster 3 days before the spleen was
removed. The booster injection used a 10 μg dose of PBA-KLH antigen
in Phosphate-buffered saline (PBS).
The boosted mouse was sacriﬁced; the spleen was removed asepti-
cally and fused with SP2/0 myeloma cells using the 50% polyethylene
glycol method as described elsewhere [8]. The resulting cells were
distributed into 10 96-well tissue culture plates at 150 μl/well. After vis-
ible colonies had formed, about 10–15 days post-fusion, culture super-
natants were screened for antibodies against PAH using a three-step
screening procedure as described in the following section.
2.4. Three-step screening procedure
In the ﬁrst step, an indirect ELISA was employed to screen positive
wells and eliminate antibodies that react with KLH. Brieﬂy, microtiter
plates were coatedwith PBA-BSA conjugatewith 5 μg/ml and incubated
at 4 °C overnight and blocked with Tween Tris buffered saline (TTBS,
0.1% Tween 20, 50 mM Tris, 1 mM EDTA, 150 mM NaCl, pH 8.0) for
1 h at room temperature with slight horizontal shaking at 300 rpm.
The culture supernatants were added to the wells for another 1 h at
room temperature on a rotator. After washing 3 times with TTBS, the
plate was incubated with GAM IgG-HRPO (dilution 1/2000 in PBS,
100 μl/well) for 1 h at room temperature. The plates were washed
117X. Li et al. / Sensing and Bio-Sensing Research 7 (2016) 115–120three times with TTBS and then developed using a solution containing
7.7 μmol of 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) and
10 μl of 30% H2O2 in 10 ml of citrate buffer (10 mM citric acid, pH 4.0).
Absorption values were measured at 405 nm with a microtiter plate
reader.
Plate wells containing hybridomas demonstrating signiﬁcant
reactionwith PBA-BSAwere selected for the second step screening pro-
cedure. Indirect competitive ELISA (icELISA)was employed by using the
original PAH derivative (PBA) as inhibitor to ascertain the relative
afﬁnity for the free PAH apart from the KLH or BSA. The icELISA proce-
dure was similar to that of indirect ELISA, except that high and zero
concentrations of PBA working solutions (50 μl respectively mixed
with the same volume of supernatants from one hybridoma well were
added)were used. The inhibition curveswere obtained through the cal-
culation of the difference between the concentrations of PBA working
solutions and inhibition values. The inhibition values were expressed
as % B/B0, where B was the absorbance at each concentration of PBA
and B0 was the absorbance in the absence of PBA [3].
Hybridomas presenting good inhibition with PBA were selected
for clonal expansion. Clonality was ensured via limiting dilution [8].
Multiple icELISAs were employed for the ﬁnal competitive screening
assay after the chosen cell lines had been fully cloned. The icELISA
procedure was in the same format as described above except that
multiple free PAHs were used as inhibitors to characterize the
antibody. Both unsubstituted and methylated PAHs were used,
includinganthracene, phenanthrene, chrysene, pyrene, benzo(a)pyrene,
2-methylphenanthrene, 9,10-dimethylanthracene, 7,12
dimethybenz(a)anthracene, 4-methyl dibenzothiophene and 2,3,5-
trimethyl naphthalene.
2.5. Selectivity determinations
The antibody was prepared on a large scale as ascetic ﬂuid, by inoc-
ulating the hybridoma cells into pristine-primed BALB/c mice. The IgG
fractions were separated and puriﬁed by the protein A column method
[12]. The selectivity of the puriﬁed antibodywas determined by calcula-
tion of the Krel values [22]. The Krel was calculated by following
formula: Krel= (IC50 of reference analyte)/(IC50 of analyte X). Typically,Fig. 2. Radar plot of Krel values of 2G8 with unsubstituted and mthe homologous analyte that corresponds to the immunization hapten
was used as the reference analyte. For the selectivity comparison,
pyrene was deﬁned as the reference analyte in this study.
2.6. Biosensor development
The KinExA Inline biosensor was prepared according to our previous
publications with small modiﬁcations [5,25]. Brieﬂy, the immobilized
antigen PBA-BSA was coated onto polymethylmethacrylate beads and
the anti-PAH mAb 2G8 was tagged with the ﬂuorescent dye Alexa
Fluor 647 by following the standard protocol provided by Thermo Fisher
Scientiﬁc [2]. The automated sample handling program of the biosensor
was described previously [5].
Several calibration curves were obtained by using different PAH
formulations as standards to evaluate mAb 2G8's performance on the
biosensor. The formulationswere phenanthrene, pyrene, a PAHmixture
solution (containing equal concentrations of anthracene,
benzo(a)pyrene, chrysene, phenanthrene and pyrene) and the com-
mercial PAH mixture containing 24 PAHs, National Institute of Stan-
dards & Technology (NIST) Standard Reference Material 2260 (SRM
2260), Aromatic Hydrocarbons in Toluene. The biosensor response
(dV) was obtained via a six-point calibration curve within the most lin-
ear range of the instrument. For each formulation standard, the calibra-
tion curves and biosensor linear range were determined by log-linear
regression analysis. To assess the accuracy of the KinExA Inline Biosen-
sor in determining total PAH concentrations in environmental samples
a variety of aqueous samples were evaluated by GC–MS and biosensor,
including sediment pore water and water-soluble fractions derived
from Prudhoe Crude Oil and creosote.
2.7. GC–MS analyses of total PAHs of estuarine samples
The above environmental sampleswere analyzed by gas chromatog-
raphy–mass spectrometry (GC–MS). The method was based on the
techniques developed previously [27]. Brieﬂy, the water samples were
ﬁltered using a 0.45 μm Millipore ﬁlter, transferred to a precleaned
separatory funnel, surrogate standards (1,4-dichlorobenzene-d4,
naphthalene-d8, acenaphthene-d10, phenanthrene-d10, chrysene-d12,ethylated PAHs. (Krel2G8 = IC50 of pyrene/IC50 of PAH X).
Table 1
Comparison of sensitivity of 2G8 with commercially available anti-PAH mAbs.
Compound IC50μg/L
2G8a 10C10b 4D5b
Benzo(a)pyrene 1.68 ± 0.97 2.77 ± 1.01 2.77 ± 1.01
Chrysene 3.84 ± 1.85 4.57 ± 0.91 5.48 ± 0.91
Pyrene 3.84 ± 1.69 6.88 ± 1.21 4.25 ± 1.01
Phenanthrene 9.44 ± 0.84 6.95 ± 0.89 11.41 ± 1.43
Anthracene 5.88 ± 1.29 8.20 ± 0.89 12.65 ± 1.60
a The IC50 values of 2G8 were means ± standard deviations for 5 times repetition.
b 10C10 and 4D5 both commercially available anti-PAHmAbs, the IC50 values for them
came from analysis in [14].
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added, and extracted three times with 20 ml of dichloromethane
(Burdick & Jackson, Muskegon, MI, USA). The volume was reduced
under a gentle stream of nitrogen using a TurboVap® evaporator
(Zymark Corp., Hopkinton, MA, USA) and the internal standard p-
terphenyl (ChemService, West Chester, PA, USA) was added. The
extracts were analyzed on a Varian 3400 Gas Chromatograph using a
Varian CP-8200 Autosampler coupled to a Saturn 4D GC/MS/MS ion
trap MS (Varian Inc., Walnut Creek, CA, USA) operated in electron
ionization (EI) mode (70 eV). It was equipped with a split/splitless
injector maintained at 320 °C. The carrier gas was He and injections
were made in splitless mode on a DB5, 60 m × 0.32 mm × 0.25 μm
ﬁlm thickness capillary column from J&W Scientiﬁc (Folsom, CA, USA).
The GC temperature program was 75 °C to 350 °C at 4 °C/min with
an initial hold of 1 min, ﬁnal hold time was 1.25 min. The manifold
and the transfer line temperatureswere 270 °C and 315 °C, respectively.
Scans were 100 to 500 m/z for 6 to 71 min; selected ions were used
to quantify the targeted analytes. A seven to ten point calibration
curve was used for the analyses of individual analytes with the Varian
MS Workstation software package, version 5.2 (Varian). The limit
of detection was approximately 0.01 μg/L per analyte. A laboratory
blank (deionized water) was processed with each set of water samples.Fig. 3. Trace plots obtained for the Biosensor during the assessment of known concentrations
inhibition and concentration of pyrene (standard curve).3. Results and discussion
3.1. Immunization
The PBA-KLH conjugate induced four out of ﬁve Balb/c mice
to produce hapten-selective antibodies 3 weeks after the initial
immunization. The titers of antibodies were enhanced with the in-
crease of inoculation times. After six weeks post-immunization,
one of the ﬁve mice tested (mouse E) gave the highest sera titer
(33,333 U/ml). The sera of mouse E also presented reaction capabil-
ity to some free PAHs, including phenanthrene, pyrene and
benzo(a)pyrene (data not shown). Since the main aim of this study
was to develop an anti-PAHs antibody with generic selectivity,
mouse E was chosen for B-lymphocyte donation for the subsequent
fusion experiments.3.2. Monoclonal antibody screening
Fifteen to twenty days after cell fusion, 590 colonies were visible
to the naked eye in the 96-well tissue culture plates. A three-step
screening procedure was applied to develop generic antibodies
against PAHs, including indirect ELISA, icELISA and multiple icELISA.
Antibodies produced by a hapten-carrier antigen include antibodies
against the hapten, the carrier and also various mixtures of these
molecules [10]. So the carrier protein used for screening was BSA,
which is different from the immunization protein (KLH) thus
preventing any positives due to the protein carrier (KLH) during
the antigen screening process. Thirty-eight positive hybridomas
were screened out by the ﬁrst step. Finally 4 stable clones were
obtained after the entire three-step screening procedure. All of
these four clones demonstrated signiﬁcant inhibition for free PAHs
(Table S2). One of the clones produced (2G8) was selected for fur-
ther detailed examination based on its general selectivity and high
sensitivity to a variety of 3–5 ring PAH.of pyrene (concentration depicted on right, μg/L). Inset: The relationship between signal
Fig. 4. Calibration curves for solutions containing either phenanthrene, pyrene, SRM 2260
Aromatic Hydrocarbons in Toluene (Table S1) and 5 PAH mixture (phenanthrene,
anthracene, chrysene, pyrene, and benzo(a)pyrene). The log-linear lines of best ﬁt are
displayed for each solution tested. The coefﬁcients of variation (n = 2) were between
0.9% and 4.8%.
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To determine whether the mAb 2G8 was a suitable antibody to be
used in the biosensor for total PAHs detection, we evaluated the sensi-
tivity and selectivity of puriﬁed mAb 2G8 by icELISAs. Unsubstituted
free PAHs as well as commonly detected environmental methylated
PAHs were employed as inhibitors in icELISAs. The inhibition curves of
2G8 against 10 different PAHs are presented in Fig. 1. IC50 values
(concentration of inhibitor that produces a 50% decrease of the
maximum normalized response) were marked as an indicator of the
antibody sensitivity. 2G8 demonstrated similar low IC50 values when
unsubstituted PAHswere employed (Fig. 1(A)),with IC50 values ranging
from 1.68 μg/L to 9.44 μg/L. In addition, 2G8 also demonstrated good
inhibitions against methylated PAHs, with IC50 values against 2-
methylphenanthrene, 9,10-dimethylanthracene, 7,12
dimethybenz(a)anthracene, 4-methyl dibenzothiophene ranging from
1.92 μg/L to 31 μg/L (Fig. 1(B)). The exceptionwas 2,3,5-trimethyl naph-
thalene. 2G8wasnot very sensitive to this compound,with an IC50 value
of 350 μg/L (data not shown). The results demonstrated that 2G8 has
low afﬁnity for 2-ring PAHs.
The validation of the antibody-based immunoassay for total PAH
quantiﬁcation in environmental samples is difﬁcult, as PAHs commonly
occur as complex mixtures. It is well documented that methylated
speciesmay comprise a large fraction of the PAHs in petrogenic samples
[20]. For this reason, the deﬁnition of total PAHs was broadened to
include the sum of unsubstituted and methylated PAHs [25]. Therefore,Table 2
Comparison of PAH determinations between biosensor and GC–MS for environmental
samples.
Sample IDa Biosensor PAH μg/L GC–MS PAH
3–5 ring μg/L Total μg/L
MP5-1 13.36 20.28 66.93
MP5-3 1.90 4.91 6.37
MP5-4 7.53 9.38 19.91
MP5-5 5.22 7.70 12.53
MP5-7 5.81 8.48 12.38
MP5-8 98.72 85.69 1131.19
MP5-9 7.67 11.13 112.76
ATL Wood Sed H2O 47.57 37.17 140.46
Prudhoe Crude Oil 36.03 16.03 314.38
Creosote 379.23 285.48 2301.19
a Sample IDs MP5 1–9 are sediment pore water samples.5 methylated PAHs which are frequently found in environmental sam-
ples were also tested. The inhibition curves of 2G8 against methylated
PAHs indicated that 2G8 is very sensitive against not only unsubstituted
PAHs but also for most of methylated PAHs.
The selectivity of 2G8 for the evaluated PAHs was also determined
by Krel value,which permits an easy relative comparison of the selectiv-
ity between the various analytes. In regards to PBA, which was our
original hapten in this study,we deﬁned pyrene as the reference analyte
to calculate Krel values (Krel for pyrene was set to 1.00). The Krels of
2G8 for different PAHs are shown in Fig. 2 by radar plots. It can clearly
be seen that the length of each ray from the central point is almost the
same, which demonstrated 2G8 performed nearly uniformly in regards
to Krel values with a wide range of PAHs, including 5 unsubstituted
PAHs and 4 methylated PAHs. As an example, the Krel value of 2G8 for
anthracene is 0.65 and the Krel value for 9,10-dimethylanthracene is
1.54. Both values are within a factor of the reference value 1.00.
Previous studies have been published evaluating antibody selectivity
for the 16 EPA priority pollutants [18,23]. However, bindingwithmeth-
ylated PAHs should also be included to evaluate the utility of quantify-
ing total PAH in complex environmental mixtures. Although some of
the previous studies showed sensitive antibodies that had some cross-
reactivity with selected PAHs, our current antibody, 2G8 has shown
nearly uniform selectivity for most 3–5 ring, methylated, and
unsubstituted PAHs tested; and is well suited for the analysis of total
PAH concentrations in environmental samples.
Focused on the potential application to quantifying complex
mixtures, the IC50 values of 2G8were comparedwith two commercially
available PAHmAbs 10C10 and 4D5 [6,14] (Table 1). The results showed
that the sensitivity of 2G8 was comparable with commercially available
10C10 and 4D5 against the ﬁve PAHs evaluated in this study. The mAbs
10C10 and 4D5were originally derived by Gomes and Santella [6] using
6-amino-BaP-BSA (BaP 6-isocyanate hapten) as the immunogen. It is
probably the reason why 10C10 and 4D5 showed the highest afﬁnity
for BaP. Meanwhile, due to the 4 ring PBA-KLH immunogen used in
this study, the selectivity of 2G8 for benzo(a)pyrene, pyrene, chrysene,
phenanthrene and anthracene were closer, especially the IC50 values
of 2G8 against anthracene at 5.88 ± 1.29 μg/L.
Antibody selection plays a central role in immunoassay develop-
ment. Understanding the antibody afﬁnity and selectivity properties
determines the applicability of the assay. A good generic PAH antibody
would allow accurate total PAH assessments of environmental samples
from a wide range of sources as opposed to a selective one. As is
discussed above, 2G8 possesses the following features: (1) very sensi-
tive to both 3–5 ring unsubstituted and methylated PAHs (Fig. 1);
(2) nearly uniformly recognition with different classes of PAHs (Fig.
2); (3) superior IC50 values and more consistent selectivity compared
with commercially available anti-PAH antibodies (Table 1). These ﬁnd-
ings imply that the generic anti-PAH antibody 2G8 was an excellent
candidate to employ in our biosensor system.
3.4. Calibration curves for the 2G8 biosensor
To evaluate the application of 2G8 in the biosensor, pyrene standard
solutions were used to assess the signal response of 2G8 across a range
of PAH concentrations (Fig. 3). A 2G8 concentration of 3.8 μg/ml result-
ed in a voltage change (dV) of approximately 1 V in blank water
samples. The biosensor relies on a competitive inhibition of antibody
binding to free PAH in solution vs. bound PAH within the detection
cell which is similar to an icELISA, therefore, the biosensor signal (dV)
decreases with the increase of the inhibitor (pyrene) concentration. In
addition, there is a linear relationship between pyrene concentration
and dV.
Phenanthrene, pyrene, the 5 PAHs mixture and the SRM2260 were
employed to generate calibration curves. The log-linear curves for the
four calibration standards are shown in Fig. 4. The concentrations of
these solutions ranged from 0.2 to 10.0 μg/L and each standard was
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slopeswith good correlation (r2= 0.94–0.99). Near overlapped calibra-
tion curves were obtained from phenanthrene, pyrene and 5 PAH
mixture, which demonstrates that the biosensor signal response is sim-
ilar when either pyrene or a 3–5 ring PAH mixture is employed for
calibration. However, the calibration curve of SRM2260 deviates slightly
from the other curveswith less detector response due to the presence of
2 ring PAHs in the SRM2260mixture (Table S1) that are not recognized
by our 2G8 antibody.
3.5. Environmental sample analysis
To evaluate the accuracy of the 2G8 biosensor for the quantiﬁcation
of total PAHs in a variety of environmental samples, the results from the
biosensor and conventional GC–MS were compared. A total of 10 envi-
ronmental samples ranging from water-soluble fractions derived from
oil and creosote to sediment pore waters were analyzed (Table 2). The
PAH concentrations of samples ranged from less than 10 to over
1000 μg/L. Samples that exceeded the upper limit of calibration
(2.5 μg/L) were diluted with deionized water. Comparable results
were obtained for total 3–5 ring PAH concentrations with the biosensor
and GC–MS (Table 2). However, if we include 2-ring PAH concentra-
tions in the results from GC–MS, the limitations of the selectivity of
2G8 to 3–5 ring compounds are evident.We continue towork on devel-
opment of mAbs against 2 ring PAHs to enhance the ability to detect
these compounds that are present in high concentrations in some
environmental samples. The biosensor results for the water soluble
fraction derived from oil are higher than GC–MS and are likely ex-
plained by the complex nature of this sample that included many
substituted PAHs that were below the quantitation limit of GC–MS but
were detected by the antibody and contributed to the reported total.
4. Conclusion
A very sensitive generic mAb (2G8) against both 3–5 ring
unsubstituted and methylated PAHs has been developed through a
three-step hybridoma screening procedure. 2G8 has been successfully
applied on the KinExA Inline Biosensor for quantifying total 3–5 ring
PAH concentrations in a variety of aqueous environmental samples in-
cluding sediment porewater. The high sensitivity and small sample vol-
umes (1–5mls) required by the biosensor allows convenient analysis of
difﬁcult to obtain environmental samples such as sediment porewaters.
Total 3–5 ring PAH quantiﬁcation compared favorably with GC–MS and
themethod can also be applied as a screening tool for sample prioritiza-
tion for further GC–MS analysis when compound speciﬁc analysis is
required. The method is low cost on a per sample basis, is rapid when
compared with conventional chromatographic methods and shows
great promise for rapid monitoring of PAH pollution.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.sbsr.2016.02.003.
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